Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.
Launched by UNIVERSITY HOSPITAL, LILLE · May 17, 2018
Trial Information
Current as of June 14, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is looking at how well healthy brothers and sisters of children with certain types of cancer (malignant haematology) understand the information they receive about their sibling's illness. The goal is to see how these siblings experience and process the information about their brother or sister's diagnosis and treatment. This study is taking place at the Centre Hospitalier Régional et Universitaire of Lille and is currently recruiting participants.
To be eligible, children must be between 6 and 12 years old and be the sibling of a child who has been diagnosed with malignant haematopathy within the last year. The parents must be able to give their consent for their child to participate, and the healthy sibling should be able to answer questions on their own during a guided interview. Participants can expect to share their feelings and thoughts about their sibling's cancer experience, which may help improve how families receive information in the future. It's important to note that children under 6 or over 12, as well as those with certain health issues, cannot participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children from 6 to 12 years old
- * Brother or sister of a child:
- • O has malignant haemopathy O follow-up in the pediatric hematology department in Lille, O diagnosed from 6 weeks to 1 year before maintenance of the healthy subject included
- • whose parents are able to understand and sign voluntarily informed consent
- • Affiliated to a social security scheme
- • Ability to understand and answer questions alone during the semi-structured interview
- Exclusion Criteria:
- • Child under 6 years or over 12 years
- • Subject with a pathology that may interfere with the course of the study, according to the investigator's assessment
- • Absence of the informed consent of one of the parents and / or the legal representative
- • Refusal of participation of the subject
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, , France
Patients applied
Trial Officials
Eva De Berranger, MD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials